Skip to Main Content

Author Details

Michael A Davies
The University of Texas MD Anderson Cancer Center
1997
289
81
PMIDPaper TitleJournal TitlePublished Year
37622466Leptomeningeal disease in melanoma: An update on the developments in pathophysiology and clinical care.Pigment Cell Melanoma Res2024
37622466Leptomeningeal disease in melanoma: An update on the developments in pathophysiology and clinical care.Pigment Cell Melanoma Res2024
36054930A distinct pattern of growth and RAC1 signaling in melanoma brain metastasis cells.Neuro Oncol2023
36166093Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma.Clin Cancer Res2023
36054930A distinct pattern of growth and RAC1 signaling in melanoma brain metastasis cells.Neuro Oncol2023
37647056Gut Microbiome in Patients With Early-Stage and Late-Stage Melanoma.JAMA Dermatol2023
37414216Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemia.Ann Oncol2023
37093838Diversity, equity, and inclusion in the melanoma research community.Pigment Cell Melanoma Res2023
37285560Beta-Blocker Use Is Associated With Worse Relapse-Free Survival in Patients With Head and Neck Cancer.JCO Precis Oncol2023
37213225Loss of AMPKα2 promotes melanoma tumor growth and brain metastasis.iScience2023
36711814Dasatinib Resensitizes MAPK Inhibitor Efficacy in Standard-of-Care Relapsed Melanomas.bioRxiv2023
36510640Changes in outcomes and factors associated with survival in melanoma patients with brain metastases.Neuro Oncol2023
36894629Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma.Nature2023
36871660Multiplatform Analysis of Intratumoral PTEN Heterogeneity in Melanoma.J Invest Dermatol2023
36627494Author Correction: Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.Nature2023
37444561Co-Targeting FASN and mTOR Suppresses Uveal Melanoma Growth.Cancers (Basel)2023
36477181Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases.Clin Cancer Res2023
36997799Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results.Nat Med2023
37503252Inflammation induced by tumor-associated nerves promotes resistance to anti-PD-1 therapy in cancer patients and is targetable by interleukin-6 blockade.Res Sq2023
37503252Inflammation induced by tumor-associated nerves promotes resistance to anti-PD-1 therapy in cancer patients and is targetable by interleukin-6 blockade.Res Sq2023
37647056Gut Microbiome in Patients With Early-Stage and Late-Stage Melanoma.JAMA Dermatol2023
37285560Beta-Blocker Use Is Associated With Worse Relapse-Free Survival in Patients With Head and Neck Cancer.JCO Precis Oncol2023
37213225Loss of AMPKα2 promotes melanoma tumor growth and brain metastasis.iScience2023
37414216Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemia.Ann Oncol2023
37444561Co-Targeting FASN and mTOR Suppresses Uveal Melanoma Growth.Cancers (Basel)2023
36997799Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results.Nat Med2023
37093838Diversity, equity, and inclusion in the melanoma research community.Pigment Cell Melanoma Res2023
36477181Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases.Clin Cancer Res2023
36871660Multiplatform Analysis of Intratumoral PTEN Heterogeneity in Melanoma.J Invest Dermatol2023
36711814Dasatinib Resensitizes MAPK Inhibitor Efficacy in Standard-of-Care Relapsed Melanomas.bioRxiv2023
36510640Changes in outcomes and factors associated with survival in melanoma patients with brain metastases.Neuro Oncol2023
36894629Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma.Nature2023
36627494Author Correction: Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.Nature2023
36166093Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma.Clin Cancer Res2023
34152638Re-thinking therapeutic development for CNS metastatic disease.Exp Dermatol2022
35912544Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities.Pigment Cell Melanoma Res2022
35706413Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint Inhibition.Cancer Immunol Res2022
35705814Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.Nature2022
35762249Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions.Neuro Oncol2022
36289334Neoadjuvant relatlimab and nivolumab in resectable melanoma.Nature2022
35810190Multi-modal molecular programs regulate melanoma cell state.Nat Commun2022
35803246Dissecting the treatment-naive ecosystem of human melanoma brain metastasis.Cell2022
35552271LFA-1 activation enriches tumor-specific T cells in a cold tumor model and synergizes with CTLA-4 blockade.J Clin Invest2022
35413951Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy.Nat Commun2022
36324592Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma.Front Oncol2022
35537412Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity.Cancer Cell2022
35977349Clinical Activity of Mitogen-Activated Protein Kinase-Targeted Therapies in Patients With Non-V600 BRAF-Mutant Tumors.JCO Precis Oncol2022
36518525Single-cell CRISPR immune screens reveal immunological roles of tumor intrinsic factors.NAR Cancer2022
34152638Re-thinking therapeutic development for CNS metastatic disease.Exp Dermatol2022
35278716Outcomes After Sphincter-Sparing Local Therapy for Anorectal Melanoma: 1989 to 2020.Pract Radiat Oncol2022
  • 1 - 50 of 578

Recommended Authors

Katie M Campbell
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 2014
Number of shared co-authors 6
Malaka Ameratunga
Australia Central Clinical School, Monash University
Career Start Year 2014
Number of shared co-authors 0
Brian J Capaldo
Center for Cancer Research, National Cancer Institute
Career Start Year 2012
Number of shared co-authors 1
Gareth Rivalland
Auckland City Hospital
Career Start Year 2010
Number of shared co-authors 0
Eliezer M Van Allen
Dana-Farber Cancer Institute
Career Start Year 2009
Number of shared co-authors 37
Maxim Sidorov
California Pacific Medical Center Research Institute
Career Start Year 2009
Number of shared co-authors 0
Jesse M Zaretsky
University of California los angeles
Career Start Year 2007
Number of shared co-authors 8
Heidi V N K??sters-Vandevelde
Canisius Wilhelmina Hospital
Career Start Year 2006
Number of shared co-authors 0
Rodrigo Dienstmann
Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus
Career Start Year 2006
Number of shared co-authors 10
Alan H Bryce
Mayo Clinic
Career Start Year 2006
Number of shared co-authors 3
Joshua C Anderson
University of Alabama at Birmingham
Career Start Year 2005
Number of shared co-authors 1
Christine A Pratilas
Johns Hopkins University School of Medicine
Career Start Year 2004
Number of shared co-authors 9
Matthias Preusser
Medical University of Vienna
Career Start Year 2003
Number of shared co-authors 10
Daniel Zingg
Netherlands Cancer Institute
Career Start Year 2001
Number of shared co-authors 5
Daniela Mihic-Probst
University Hospital Zurich
Career Start Year 2001
Number of shared co-authors 8
Christopher D Willey
University of Alabama at Birmingham
Career Start Year 2000
Number of shared co-authors 1
Martijn P Lolkema
Erasmus MC Cancer Institute
Career Start Year 1999
Number of shared co-authors 9
Bartosz Chmielowski
Jonsson Comprehensive Cancer Center, University of California Los Angeles
Career Start Year 1999
Number of shared co-authors 10
David J Liewehr
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 3
Travis J Hollmann
Memorial Sloan Kettering Cancer Center
Career Start Year 1998
Number of shared co-authors 9
Cindy Sander
UPMC Hillman Cancer Center
Career Start Year 1997
Number of shared co-authors 12
Anthony M Joshua
The Kinghorn Cancer Centre, St. Vincent's Hospital Sydney
Career Start Year 1997
Number of shared co-authors 7
Katherine S Panageas
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 11
Lillian L Siu
Princess Margaret Cancer Centre, University Ave
Career Start Year 1995
Number of shared co-authors 15
Stefan Sleijfer
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year 1994
Number of shared co-authors 1
Timothy A Chan
Cleveland Clinic.
Career Start Year 1994
Number of shared co-authors 39
Craig Gedye
Hunter Medical Research Institute, University of Newcastle
Career Start Year 1993
Number of shared co-authors 6
Rene Gonzalez
University of Colorado Anschutz Medical Campus
Career Start Year 1990
Number of shared co-authors 24
Suresh Nair
Lehigh Valley Topper Cancer Institute
Career Start Year 1990
Number of shared co-authors 8
Emile E Voest
The Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 3

Collaborators

Jeffrey E Gershenwald
The University of Texas MD Anderson Cancer Center
Co-authored papers 62
Jennifer A Wargo
Co-authored papers 58
Alexander J Lazar
The University of Texas MD Anderson Cancer Center
Co-authored papers 54
Hussein A Tawbi
MD Anderson Cancer Center
Co-authored papers 50
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 34
Georgina V Long
Co-authored papers 31
Andrew E Aplin
Thomas Jefferson University
Co-authored papers 19
Meenhard Herlyn
Ellen and Ronald Caplan Cancer Center, The Wistar Institute
Co-authored papers 17
Guo Chen
China Pharmaceutical University
Co-authored papers 16
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Co-authored papers 15
Dirk Schadendorf
Co-authored papers 14
Yiling Lu
Co-authored papers 14
Lawrence N Kwong
The University of Texas MD Anderson Cancer Center
Co-authored papers 13
Richard A Scolyer
Co-authored papers 11
Antoni Ribas
University of California Los Angeles (university of california los angeles)
Co-authored papers 11
Katherine Stemke-Hale
MD Anderson Cancer Center, University of Texas
Co-authored papers 11
Caroline Robert
Co-authored papers 10
Scott Kopetz
University of Texas MD Anderson Cancer Center
Co-authored papers 10
Funda Meric-Bernstam
University of Texas MD Anderson Cancer Center
Co-authored papers 10
Mark J Routbort
University of Texas MD Anderson Cancer Center
Co-authored papers 10
Katherine L Nathanson
Perelman School of Medicine, University of Pennsylvania, USA Abramson Cancer Center
Co-authored papers 10
Dave S B Hoon
Saint John's Cancer Institute at Saint John's Health Center
Co-authored papers 9
Linghua Wang
The University of Texas M. D. Anderson
Co-authored papers 9
Reinhard Dummer
University Hospital Zurich
Co-authored papers 8
Jianhua Hu
Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences
Co-authored papers 8
Janice N Cormier
Co-authored papers 8
Priscilla K Brastianos
Co-authored papers 8
Marcus Bosenberg
Yale School of Medicine
Co-authored papers 8
Yardena Samuels
Weizmann Institute of Science
Co-authored papers 8
Sherise D Ferguson
The University of Texas MD Anderson Cancer Center
Co-authored papers 8
Release 1.2